PCM
Peregrine Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-168,790
| Closed | -$36.3M | – | 353 |
|
|
2021
Q1 | $36.3M | Buy |
168,790
+12,168
| +8% | +$2.61M | 0.67% | 26 |
|
|
2020
Q4 | $37M | Buy |
156,622
+19,742
| +14% | +$4.67M | 0.7% | 28 |
|
|
2020
Q3 | $37.2M | Buy |
136,880
+896
| +0.7% | +$244K | 0.99% | 16 |
|
|
2020
Q2 | $39.5M | Buy |
135,984
+4,311
| +3% | +$1.25M | 1.12% | 10 |
|
|
2020
Q1 | $31.3M | Buy |
131,673
+1,032
| +0.8% | +$246K | 1.12% | 6 |
|
|
2019
Q4 | $28.6M | Buy |
130,641
+498
| +0.4% | +$109K | 0.73% | 30 |
|
|
2019
Q3 | $22M | Buy |
130,143
+17,324
| +15% | +$2.94M | 0.6% | 52 |
|
|
2019
Q2 | $20.7M | Hold |
112,819
| – | – | 0.51% | 72 |
|
|
2019
Q1 | $20.8M | Buy |
112,819
+1,341
| +1% | +$247K | 0.52% | 70 |
|
|
2018
Q4 | $18.5M | Buy |
111,478
+13,601
| +14% | +$2.25M | 0.52% | 68 |
|
|
2018
Q3 | $18.9M | Hold |
97,877
| – | – | 0.45% | 101 |
|
|
2018
Q2 | $16.6M | Buy |
97,877
+21,430
| +28% | +$3.64M | 0.42% | 111 |
|
|
2018
Q1 | $12.5M | Buy |
+76,447
| New | +$12.5M | 0.3% | 128 |
|